It is assumed ZEN would have the ability to give guidance in the trial. But them again thats an assumption. This dog is the only hope I see for us making a win at some point in respect to an investment..and that is a trepid perspective when we look at our team of non-performers.We can say with confidence that we are not leading the field in epigenics as the CEO has made the claims so many times previous,,,if we ever had a lead its in the rear view mirror no doubt. The other company will get thrown into the mix if ZEN gets taken out,,,,it will be gifted to the aggressor imo, and just as well!,,,our team has been a group of cave men looking at a coke can for decades,,,hopefully ZEN makes inroads with the management teams of these third party players!,,again just a personal opinion from watching and filling in the blanks over the past multiple years!!!